Published online September 1, 2004
PEDIATRICS Vol. 114 No. 3 September 2004, pp. 793-804 (doi:10.1542/peds.2004-0434)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, S. K.
Right arrow Articles by Pickering, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, S. K.
Right arrow Articles by Pickering, L. K.
Related Collections
Right arrow Infectious Disease & Immunity

Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data

Sarah K. Parker, MD*, Benjamin Schwartz, MD{ddagger}, James Todd, MD* and Larry K. Pickering, MD{ddagger}

* Department of Pediatrics, Children's Hospital and University of Colorado Health Sciences Center, Denver, Colorado
{ddagger} National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia

Objective. The issue of thimerosal-containing vaccines as a possible cause of autistic spectrum disorders (ASD) and neurodevelopmental disorders (NDDs) has been a controversial topic since 1999. Although most practitioners are familiar with the controversy, many are not familiar with the type or quality of evidence in published articles that have addressed this issue. To assess the quality of evidence assessing a potential association between thimerosal-containing vaccines and autism and evaluate whether that evidence suggests accepting or rejecting the hypothesis, we systematically reviewed published articles that report original data pertinent to the potential association between thimerosal-containing vaccines and ASD/NDDs.

Methods. Articles for analysis were identified in the National Library of Medicine's Medline database using a PubMed search of the English-language literature for articles published between 1966 and 2004, using keywords thimerosal, thiomersal, mercury, methylmercury, or ethylmercury alone and combined with keywords autistic disorder, autistic spectrum disorder, and neurodevelopment. In addition, we used the "related links" option in PubMed and reviewed the reference sections in the identified articles. All original articles that evaluated an association between thimerosal-containing vaccines and ASD/NDDs or pharmacokinetics of ethylmercury in vaccines were included.

Results. Twelve publications that met the selection criteria were identified by the literature search: 10 epidemiologic studies and 2 pharmacokinetic studies of ethylmercury. The design and quality of the studies showed significant variation. The preponderance of epidemiologic evidence does not support an association between thimerosal-containing vaccines and ASD. Epidemiologic studies that support an association are of poor quality and cannot be interpreted. Pharmacokinetic studies suggest that the half-life of ethylmercury is significantly shorter when compared with methylmercury.

Conclusions. Studies do not demonstrate a link between thimerosal-containing vaccines and ASD, and the pharmacokinetics of ethylmercury make such an association less likely. Epidemiologic studies that support a link demonstrated significant design flaws that invalidate their conclusions. Evidence does not support a change in the standard of practice with regard to administration of thimerosal-containing vaccines in areas of the world where they are used.

Key Words: thimerosal • thiomersal • mercury • vaccine • methylmercury • ethylmercury • autism • autistic disorder • autistic spectrum disorder • developmental disorder • neurodevelopmental disorder

Abbreviations: ASD, autistic spectrum disorders • MMR, measles, mumps, rubella • EPA, Environmental Protection Agency • FDA, Food and Drug Administration • NDD, neurodevelopmental disorder • VAERS, Vaccine Adverse Events Reporting System • AE, adverse event • DTaP, diphtheria, tetanus, acellular pertussis • CI, confidence interval • CDC, Centers for Disease Control and Prevention • DTP, diphtheria, tetanus, whole-cell pertussis • HMO, health maintenance organization • RR, relative risk • ADD, attention-deficit disorder • GPRD, General Practice Research Database • DT, diphtheria, tetanus

Accepted May 19, 2004.




This article has been cited by other articles:


Home page
 PediatricsHome page
M. E. Pichichero, A. Gentile, N. Giglio, V. Umido, T. Clarkson, E. Cernichiari, G. Zareba, C. Gotelli, M. Gotelli, L. Yan, et al.
Mercury Levels in Newborns and Infants After Receipt of Thimerosal-Containing Vaccines
Pediatrics, February 1, 2008; 121(2): e208 - e214.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
E. Fombonne
Thimerosal Disappears but Autism Remains
Arch Gen Psychiatry, January 1, 2008; 65(1): 15 - 16.
[Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
R. Schechter and J. K. Grether
Continuing Increases in Autism Reported to California's Developmental Services System: Mercury in Retrograde
Arch Gen Psychiatry, January 1, 2008; 65(1): 19 - 24.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. A. Offit
Thimerosal and Vaccines -- A Cautionary Tale
N. Engl. J. Med., September 27, 2007; 357(13): 1278 - 1279.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. M Stachnik and C. Nunn-Thompson
Use of Atypical Antipsychotics in the Treatment of Autistic Disorder
Ann. Pharmacother., April 1, 2007; 41(4): 626 - 634.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. Fombonne, R. Zakarian, A. Bennett, L. Meng, and D. McLean-Heywood
Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations
Pediatrics, July 1, 2006; 118(1): e139 - e150.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Public HealthHome page
J. A. Wright and C. Polack
Understanding variation in measles-mumps-rubella immunization coverage--a population-based study
Eur J Public Health, April 1, 2006; 16(2): 137 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Med.Home page
Other articles noted
Evid. Based Med., June 1, 2005; 10(3): 95 - 96.
[Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
A. M. Stern and H. Markel
The History Of Vaccines And Immunization: Familiar Patterns, New Challenges
Health Aff., May 1, 2005; 24(3): 611 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Ment. HealthHome page
W. M McMahon
Review: vaccines containing thimerosal are not associated with autistic spectrum disorders in children
Evid. Based Ment. Health, February 1, 2005; 8(1): 23 - 23.
[Full Text] [PDF]

Home page
 PediatricsHome page
S. Parker, J. Todd, B. Schwartz, and L. Pickering
Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data
Pediatrics, January 1, 2005; 115(1): 200 - 200.
[Full Text] [PDF]